<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334959</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Single-Atom Ce-N-C Nanozyme Ameliorates Type 2 Diabetes Mellitus by Improving Glucose Metabolism Disorders and Reducing Oxidative Stress.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14091193</ELocationID><Abstract><AbstractText>Type 2 diabetes mellitus (T2DM) as a chronic metabolic disease has become a global public health problem. Insulin resistance (IR) is the main pathogenesis of T2DM. Oxidative stress refers to an imbalance between free radical production and the antioxidant system, causing insulin resistance and contributing to the development of T2DM via several molecular mechanisms. Besides, the reduction in hepatic glycogen synthesis also leads to a decrease in peripheral insulin sensitivity. Thus, reducing oxidative stress and promoting glycogen synthesis are both targets for improving insulin resistance and treating T2DM. The current study aims to investigate the pharmacological effects of single-atom Ce-N-C nanozyme (SACe-N-C) on the improvement of insulin resistance and to elucidate its underlying mechanisms using HFD/STZ-induced C57BL/6J mice and insulin-resistant HepG2 cells. The results indicate that SACe-N-C significantly improves hepatic glycogen synthesis and reduces oxidative stress, as well as pancreatic and liver injury. Specifically, compared to the T2DM model group, fasting blood glucose decreased by 29%, hepatic glycogen synthesis increased by 17.13%, and insulin secretion increased by 18.87%. The sod and GPx in the liver increased by 17.80% and 25.28%, respectively. In terms of mechanism, SACe-N-C modulated glycogen synthesis through the PI3K/AKT/GSK3β signaling pathway and activated the Keap1/Nrf2 pathway to alleviate oxidative stress. Collectively, this study suggests that SACe-N-C has the potential to treat T2DM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yitong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ruxin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Boran</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kunlun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), The Ministry of Agriculture and Rural Affairs of China, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Nan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2907-978X</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xiaoyun</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9503-8532</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), The Ministry of Agriculture and Rural Affairs of China, Beijing 100083, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023ZD0406304</GrantID><Agency>the 2115 Talent Development Program of China Agricultural University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072019">Kelch-Like ECH-Associated Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="Y">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072019" MajorTopicYN="N">Kelch-Like ECH-Associated Protein 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">glycogen synthesis</Keyword><Keyword MajorTopicYN="N">insulin resistance</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">single-atom nanozyme</Keyword><Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334959</ArticleId><ArticleId IdType="pmc">PMC11430424</ArticleId><ArticleId IdType="doi">10.3390/biom14091193</ArticleId><ArticleId IdType="pii">biom14091193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ben-Shlomo A., Fleseriu M. Diabetes Mellitus. Endocrinol. Metab. Clin. N. Am. 2016;45:xiii–xiv. doi: 10.1016/j.ecl.2016.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2016.09.002</ArticleId><ArticleId IdType="pubmed">27823616</ArticleId></ArticleIdList></Reference><Reference><Citation>Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S17–S38. doi: 10.2337/dc22-S002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-S002</ArticleId><ArticleId IdType="pubmed">34964875</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin. Pr. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2019.107843</ArticleId><ArticleId IdType="pubmed">31518657</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Li Y., Dai Y., Peng J. Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms. Pharmacol. Res. 2018;130:451–465. doi: 10.1016/j.phrs.2018.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.01.015</ArticleId><ArticleId IdType="pubmed">29395440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018;14:88–98. doi: 10.1038/nrendo.2017.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2017.151</ArticleId><ArticleId IdType="pubmed">29219149</ArticleId></ArticleIdList></Reference><Reference><Citation>Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet. 2005;365:1333–1346. doi: 10.1016/S0140-6736(05)61032-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)61032-X</ArticleId><ArticleId IdType="pubmed">15823385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C.X., Ma X.N., Guan C.H., Li Y.D., Mauricio D., Fu S.B. Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management. Cardiovasc. Diabetol. 2022;21:74. doi: 10.1186/s12933-022-01516-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01516-6</ArticleId><ArticleId IdType="pmc">PMC9107726</ArticleId><ArticleId IdType="pubmed">35568946</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.G., Liu A.X., Zhang Y.X., Zhou M.Y., Li X.Y., Fu M.H., Pan Y.P., Xu J., Zhang J.Q. A diarylheptanoid compound from Alpinia officinarum Hance ameliorates high glucose-induced insulin resistance by regulating PI3K/AKT-Nrf2-GSK3β signaling pathways in HepG2 cells. J. Ethnopharmacol. 2022;295:115397. doi: 10.1016/j.jep.2022.115397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2022.115397</ArticleId><ArticleId IdType="pubmed">35605918</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32((Suppl. S2)):S157–S163. doi: 10.2337/dc09-S302.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-S302</ArticleId><ArticleId IdType="pmc">PMC2811436</ArticleId><ArticleId IdType="pubmed">19875544</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Liu H., Liu J. Akt activation: A potential strategy to ameliorate insulin resistance. Diabetes Res. Clin. Pract. 2019;156:107092. doi: 10.1016/j.diabres.2017.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.10.004</ArticleId><ArticleId IdType="pubmed">29111280</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.S., Ji T., Su S.L., Zhu Y., Chen X.L., Shang E.X., Guo S., Qian D.W., Duan J.A. Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs/RAGE and p38 MAPK/NF-κB pathway. J. Ethnopharmacol. 2022;283:114713. doi: 10.1016/j.jep.2021.114713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.114713</ArticleId><ArticleId IdType="pubmed">34626776</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans J.L., Maddux B.A., Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox Signal. 2005;7:1040–1052. doi: 10.1089/ars.2005.7.1040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.1040</ArticleId><ArticleId IdType="pubmed">15998259</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel B.M., Goyal R.K. Liver and insulin resistance: New wine in old bottle!!! Eur. J. Pharmacol. 2019;862:172657. doi: 10.1016/j.ejphar.2019.172657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172657</ArticleId><ArticleId IdType="pubmed">31499040</ArticleId></ArticleIdList></Reference><Reference><Citation>Govers R. Cellular regulation of glucose uptake by glucose transporter GLUT4. Adv. Clin. Chem. 2014;66:173–240. doi: 10.1016/b978-0-12-801401-1.00006-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-801401-1.00006-2</ArticleId><ArticleId IdType="pubmed">25344989</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb A.E., Brunet A. FOXO transcription factors: Key regulators of cellular quality control. Trends Biochem. Sci. 2014;39:159–169. doi: 10.1016/j.tibs.2014.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2014.02.003</ArticleId><ArticleId IdType="pmc">PMC4021867</ArticleId><ArticleId IdType="pubmed">24630600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Liu Z., Lu Y., Chi X., Han K., Wang H., Wang Y., Ma L., Xu B. Glucose metabolism enhancement by 10-hydroxy-2-decenoic acid via the PI3K/AKT signaling pathway in high-fat-diet/streptozotocin induced type 2 diabetic mice. Food Funct. 2022;13:9931–9946. doi: 10.1039/D1FO03818D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1FO03818D</ArticleId><ArticleId IdType="pubmed">36056641</ArticleId></ArticleIdList></Reference><Reference><Citation>Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944–948. doi: 10.1038/nature04634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04634</ArticleId><ArticleId IdType="pubmed">16612386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman K., Akash M.S.H. Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked? J. Cell Biochem. 2017;118:3577–3585. doi: 10.1002/jcb.26097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26097</ArticleId><ArticleId IdType="pubmed">28460155</ArticleId></ArticleIdList></Reference><Reference><Citation>Baird L., Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Mol. Cell Biol. 2020;40:e00099-20. doi: 10.1128/MCB.00099-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00099-20</ArticleId><ArticleId IdType="pmc">PMC7296212</ArticleId><ArticleId IdType="pubmed">32284348</ArticleId></ArticleIdList></Reference><Reference><Citation>Uruno A., Yagishita Y., Yamamoto M. The Keap1-Nrf2 system and diabetes mellitus. Arch. Biochem. Biophys. 2015;566:76–84. doi: 10.1016/j.abb.2014.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2014.12.012</ArticleId><ArticleId IdType="pubmed">25528168</ArticleId></ArticleIdList></Reference><Reference><Citation>Manea F., Houillon F.B., Pasquato L., Scrimin P. Nanozymes: Gold-nanoparticle-based transphosphorylation catalysts. Angew. Chem. Int. Ed. Engl. 2004;43:6165–6169. doi: 10.1002/anie.200460649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200460649</ArticleId><ArticleId IdType="pubmed">15549744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D., Ni D., Rosenkrans Z.T., Huang P., Yan X., Cai W. Nanozyme: New horizons for responsive biomedical applications. Chem. Soc. Rev. 2019;48:3683–3704. doi: 10.1039/C8CS00718G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8CS00718G</ArticleId><ArticleId IdType="pmc">PMC6696937</ArticleId><ArticleId IdType="pubmed">31119258</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao B., Wang A., Yang X., Allard L.F., Jiang Z., Cui Y., Liu J., Li J., Zhang T. Single-atom catalysis of CO oxidation using Pt1/FeOx. Nat. Chem. 2011;3:634–641. doi: 10.1038/nchem.1095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchem.1095</ArticleId><ArticleId IdType="pubmed">21778984</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu B., Li S., Zheng L., Liu Y., Han A., Zhang J., Huang Z., Xie H., Fan K., Gao L., et al. A Bioinspired Five-Coordinated Single-Atom Iron Nanozyme for Tumor Catalytic Therapy. Adv. Mater. 2022;34:e2107088. doi: 10.1002/adma.202107088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202107088</ArticleId><ArticleId IdType="pubmed">35102632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao L., Yan H., Wu Y., Gu W., Zhu C., Du D., Lin Y. When Nanozymes Meet Single-Atom Catalysis. Angew. Chem. Int. Ed. Engl. 2020;59:2565–2576. doi: 10.1002/anie.201905645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201905645</ArticleId><ArticleId IdType="pubmed">31209985</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Chen J., Gan L., Wang J., Dong S. Single-atom nanozymes. Sci. Adv. 2019;5:eaav5490. doi: 10.1126/sciadv.aav5490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aav5490</ArticleId><ArticleId IdType="pmc">PMC6499548</ArticleId><ArticleId IdType="pubmed">31058221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji S.F., Jiang B., Hao H.G., Chen Y.J., Dong J.C., Mao Y., Zhang Z.D., Gao R., Chen W.X., Zhang R.F., et al. Matching the kinetics of natural enzymes with a single-atom iron nanozyme. Nat. Catal. 2021;4:407–417. doi: 10.1038/s41929-021-00609-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41929-021-00609-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li P., Yu D., Zhang Y., Wang Z., Liu C., Qiu H., Liu Z., Ren J., Qu X. Unraveling the Enzymatic Activity of Oxygenated Carbon Nanotubes and Their Application in the Treatment of Bacterial Infections. Nano Lett. 2018;18:3344–3351. doi: 10.1021/acs.nanolett.7b05095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.7b05095</ArticleId><ArticleId IdType="pubmed">29763562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Wang Y., Lu L.L., Ma Q., Feng R.X., Xu S.Y., James T.D., Wang L.Y. Reducing Valence States of Co Active Sites in a Single-Atom Nanozyme for Boosted Tumor Therapy. Adv. Funct. Mater. 2022;32:202200331. doi: 10.1002/adfm.202200331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adfm.202200331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao F., Zhang L., You Y., Zheng L., Ren J., Qu X. An Enzyme-Mimicking Single-Atom Catalyst as an Efficient Multiple Reactive Oxygen and Nitrogen Species Scavenger for Sepsis Management. Angew. Chem. Int. Ed. Engl. 2020;59:5108–5115. doi: 10.1002/anie.201912182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201912182</ArticleId><ArticleId IdType="pubmed">31960567</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.C., Qin X., Xiao F., Liang C., Xu M., Meng Y., Sarnello E., Fang L., Li T., Ding S., et al. Highly Dispersive Cerium Atoms on Carbon Nanowires as Oxygen Reduction Reaction Electrocatalysts for Zn-Air Batteries. Nano Lett. 2021;21:4508–4515. doi: 10.1021/acs.nanolett.1c01493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.1c01493</ArticleId><ArticleId IdType="pubmed">33998804</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G., Zhang J., Huang H., Wang X., He X., Luo Y., Li J.C., Huang K., Cheng N. Single-atom Ce-N-C nanozyme bioactive paper with a 3D-printed platform for rapid detection of organophosphorus and carbamate pesticide residues. Food Chem. 2022;387:132896. doi: 10.1016/j.foodchem.2022.132896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2022.132896</ArticleId><ArticleId IdType="pubmed">35421648</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G., Xu J., Zhong H., Zhang Q., Wang X., Lin Y., Beckman S.P., Luo Y., He X., Li J.C., et al. Single-Atom Ce-N4-C-(OH)2 Nanozyme-Catalyzed Cascade Reaction to Alleviate Hyperglycemia. Research. 2023;6:0095. doi: 10.34133/research.0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.34133/research.0095</ArticleId><ArticleId IdType="pmc">PMC10062498</ArticleId><ArticleId IdType="pubmed">37011265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Zhang Y., Liu Y., Zhu D., Yu J., Li G., Sun Z., Wang W., Jiang H., Hong Z. MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling. Aging. 2019;11:7510–7524. doi: 10.18632/aging.102263.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102263</ArticleId><ArticleId IdType="pmc">PMC6781997</ArticleId><ArticleId IdType="pubmed">31562809</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Huang Z., Li H., Yu J., Wang C., Chen S., Meng Q., Cheng Y., Gao X., Li J., et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes. 2011;60:746–756. doi: 10.2337/db10-1246.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-1246</ArticleId><ArticleId IdType="pmc">PMC3046835</ArticleId><ArticleId IdType="pubmed">21282364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Li M., Sun W., Li Q., Xi H., Qiu Y., Wang R., Ding Q., Wang Z., Yu Y., et al. Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models. Pharmacol. Res. 2022;177:105917. doi: 10.1016/j.phrs.2021.105917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105917</ArticleId><ArticleId IdType="pubmed">34597809</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J., Wang C., Jin Y., Meng Q., Liu Q., Liu Z., Liu K., Sun H. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway. Pharmacol. Res. 2018;130:466–480. doi: 10.1016/j.phrs.2017.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2017.12.026</ArticleId><ArticleId IdType="pubmed">29284152</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia T., Wang Q. D-chiro-inositol found in Cucurbita ficifolia (Cucurbitaceae) fruit extracts plays the hypoglycaemic role in streptozocin-diabetic rats. J. Pharm. Pharmacol. 2006;58:1527–1532. doi: 10.1211/jpp.58.10.0014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1211/jpp.58.10.0014</ArticleId><ArticleId IdType="pubmed">17132216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong F., Ding Z., Zhang K., Duan W., Qin Y., Su Z., Bi Y. Optimization of extraction flavonoids from Exocarpium Citri Grandis and evaluation its hypoglycemic and hypolipidemic activities. J. Ethnopharmacol. 2020;262:113178. doi: 10.1016/j.jep.2020.113178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2020.113178</ArticleId><ArticleId IdType="pubmed">32736047</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Liu G., Guo J., Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 2018;14:1483–1496. doi: 10.7150/ijbs.27173.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.27173</ArticleId><ArticleId IdType="pmc">PMC6158718</ArticleId><ArticleId IdType="pubmed">30263000</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel V.T., Shulman G.I. The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux. J. Clin. Invest. 2016;126:12–22. doi: 10.1172/JCI77812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI77812</ArticleId><ArticleId IdType="pmc">PMC4701542</ArticleId><ArticleId IdType="pubmed">26727229</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnahdi A., John A., Raza H. Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid. Nutrients. 2019;11:1979. doi: 10.3390/nu11091979.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11091979</ArticleId><ArticleId IdType="pmc">PMC6770774</ArticleId><ArticleId IdType="pubmed">31443411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wu Q., Liu J., Zhang Z., Ma X., Zhang Y., Zhu J., Thring R.W., Wu M., Gao Y., et al. Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis. Biomed. Pharmacother. 2022;152:113273. doi: 10.1016/j.biopha.2022.113273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113273</ArticleId><ArticleId IdType="pubmed">35709656</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay K.K., Jadeja R.N., Vyas H.S., Pandya B., Joshi A., Vohra A., Thounaojam M.C., Martin P.M., Bartoli M., Devkar R.V. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function. Redox Biol. 2020;28:101314. doi: 10.1016/j.redox.2019.101314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101314</ArticleId><ArticleId IdType="pmc">PMC6737302</ArticleId><ArticleId IdType="pubmed">31514051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004;24:816–823. doi: 10.1161/01.ATV.0000122852.22604.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000122852.22604.78</ArticleId><ArticleId IdType="pubmed">14976002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogurtsova K., da Rocha Fernandes J.D., Huang Y., Linnenkamp U., Guariguata L., Cho N.H., Cavan D., Shaw J.E., Makaroff L.E. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.03.024</ArticleId><ArticleId IdType="pubmed">28437734</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T.Y., Shi C.X., Gao R., Sun H.J., Xiong X.Q., Ding L., Chen Q., Li Y.H., Wang J.J., Kang Y.M., et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Clin. Sci. 2015;129:839–850. doi: 10.1042/CS20150009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20150009</ArticleId><ArticleId IdType="pubmed">26201094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu C., Yu Y., Yin M., Sun J., Huang J., Chen N., Wang H., Fan C., Song H. An Organelle-Specific Nanozyme for Diabetes Care in Genetically or Diet-Induced Models. Adv. Mater. 2020;32:e2003708. doi: 10.1002/adma.202003708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202003708</ArticleId><ArticleId IdType="pubmed">33015921</ArticleId></ArticleIdList></Reference><Reference><Citation>U.K. Prospective Diabetes Study 16. Overview of 6 years’ therapy of type II diabetes: A progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995;44:1249–1258. doi: 10.2337/diab.44.11.1249.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.44.11.1249</ArticleId><ArticleId IdType="pubmed">7589820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrannini E. The stunned beta cell: A brief history. Cell Metab. 2010;11:349–352. doi: 10.1016/j.cmet.2010.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2010.04.009</ArticleId><ArticleId IdType="pubmed">20444416</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig N.A., Herrine S.K., Rubin R. Liver disease and diabetes mellitus. Clin. Lab. Med. 2001;21:193–207.</Citation><ArticleIdList><ArticleId IdType="pubmed">11321935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Zheng L., Dong D., Xu L., Yin L., Qi Y., Han X., Lin Y., Liu K., Peng J. Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem. 2013;141:2108–2116. doi: 10.1016/j.foodchem.2013.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2013.05.019</ArticleId><ArticleId IdType="pubmed">23870935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Deng J., Liu D., Tuo X., Xiao L., Lai B., Yao Q., Liu J., Yang H., Wang N. Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway. Br. J. Pharmacol. 2018;175:4218–4228. doi: 10.1111/bph.14482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14482</ArticleId><ArticleId IdType="pmc">PMC6193881</ArticleId><ArticleId IdType="pubmed">30129056</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Huang Q., Zhang L., Qiao X., Zhang Y., Tang F., Li Z. Effect of CAPE-pNO2 against type 2 diabetes mellitus via the AMPK/GLUT4/GSK3β/PPARα pathway in HFD/STZ-induced diabetic mice. Eur. J. Pharmacol. 2019;853:1–10. doi: 10.1016/j.ejphar.2019.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.03.027</ArticleId><ArticleId IdType="pubmed">30885574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., Rinfret S., Schiffrin E.L., Eisenberg M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010;56:1113–1132. doi: 10.1016/j.jacc.2010.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.05.034</ArticleId><ArticleId IdType="pubmed">20863953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimori S., Shimoda S., Goto R., Matsuo Y., Maeda T., Furukawa N., Kawashima J., Kodama S., Sekigami T., Isami S., et al. Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes. J. Diabetes Investig. 2012;3:179–184. doi: 10.1111/j.2040-1124.2011.00147.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2040-1124.2011.00147.x</ArticleId><ArticleId IdType="pmc">PMC4020737</ArticleId><ArticleId IdType="pubmed">24843563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Miao L., Xiao J., Cheang W.S. 3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress. Curr. Issues Mol. Biol. 2022;44:2175–2185. doi: 10.3390/cimb44050147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44050147</ArticleId><ArticleId IdType="pmc">PMC9164067</ArticleId><ArticleId IdType="pubmed">35678676</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia J.M., Meyer C.M., Peper C.L., Zhai L., Bock C.B., Previs S.F., McGuinness O.P., DePaoli-Roach A., Roach P.J. Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice. J. Biol. Chem. 2010;285:12851–12861. doi: 10.1074/jbc.M110.106534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.106534</ArticleId><ArticleId IdType="pmc">PMC2857087</ArticleId><ArticleId IdType="pubmed">20178984</ArticleId></ArticleIdList></Reference><Reference><Citation>Krssak M., Brehm A., Bernroider E., Anderwald C., Nowotny P., Dalla Man C., Cobelli C., Cline G.W., Shulman G.I., Waldhäusl W., et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes. 2004;53:3048–3056. doi: 10.2337/diabetes.53.12.3048.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.53.12.3048</ArticleId><ArticleId IdType="pubmed">15561933</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Zhao M.G., Jiang C.H., Sheng X.P., Yang H.M., Liu Y., Yao X.M., Zhang J., Yin Z.Q. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. Phytomedicine Int. J. Phytother. Phytopharm. 2020;66:153130. doi: 10.1016/j.phymed.2019.153130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2019.153130</ArticleId><ArticleId IdType="pubmed">31790897</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zhao Q., Zhang J., Zhou L., Zhang W., Chua B., Chen Y., Xu L., Li P. The Protein Phosphatase 1 Complex Is a Direct Target of AKT that Links Insulin Signaling to Hepatic Glycogen Deposition. Cell Rep. 2019;28:3406–3422.e3407. doi: 10.1016/j.celrep.2019.08.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.08.066</ArticleId><ArticleId IdType="pubmed">31553910</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K., Gross M., Lee D.H., Holvoet P., Himes J.H., Shikany J.M., Jacobs D.R., Jr. Oxidative stress and insulin resistance: The coronary artery risk development in young adults study. Diabetes Care. 2009;32:1302–1307. doi: 10.2337/dc09-0259.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-0259</ArticleId><ArticleId IdType="pmc">PMC2699736</ArticleId><ArticleId IdType="pubmed">19389821</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkhondeh T., Samarghandian S., Roshanravan B. Impact of chrysin on the molecular mechanisms underlying diabetic complications. J. Cell Physiol. 2019;234:17144–17158. doi: 10.1002/jcp.28488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28488</ArticleId><ArticleId IdType="pubmed">30916403</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksu E.H., Kandemir F.M., Küçükler S., Mahamadu A. Improvement in colistin-induced reproductive damage, apoptosis, and autophagy in testes via reducing oxidative stress by chrysin. J. Biochem. Mol. Toxicol. 2018;32:e22201. doi: 10.1002/jbt.22201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.22201</ArticleId><ArticleId IdType="pubmed">30273961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Jian T., Wu Y., Zuo Y., Li J., Lv H., Ma L., Ren B., Zhao L., Li W., et al. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway. Biomed. Pharmacother. 2019;110:85–94. doi: 10.1016/j.biopha.2018.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.11.018</ArticleId><ArticleId IdType="pubmed">30466006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui B., Zhang S., Wang Y., Guo Y. Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line. Biomed. Pharmacother. 2019;109:112–119. doi: 10.1016/j.biopha.2018.10.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.10.053</ArticleId><ArticleId IdType="pubmed">30396067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.G., Lee Y., Lee N., Soh M., Kim D., Hyeon T. Ceria-Based Therapeutic Antioxidants for Biomedical Applications. Adv. Mater. 2024;36:2210819. doi: 10.1002/adma.202210819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202210819</ArticleId><ArticleId IdType="pubmed">36793245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.J., Jeong H.Y., Kim Y.B., Lee Y.J., Won S.Y., Shim J.H., Cho M.K., Nam H.S., Lee S.H. Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2012;50:116–123. doi: 10.1016/j.fct.2011.10.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2011.10.035</ArticleId><ArticleId IdType="pubmed">22019695</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X., Rui W., Zhang F., Ding W. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Cell Biol. Toxicol. 2013;29:143–157. doi: 10.1007/s10565-013-9242-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10565-013-9242-5</ArticleId><ArticleId IdType="pubmed">23525690</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>